L&C BIO Co.,LTD (KOSDAQ: 290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
22,900
+100 (0.44%)
Dec 19, 2024, 11:58 AM KST
-21.58%
Market Cap 488.86B
Revenue (ttm) 70.03B
Net Income (ttm) -5.96B
Shares Out 22.68M
EPS (ttm) -262.78
PE Ratio n/a
Forward PE n/a
Dividend 100.00 (0.46%)
Ex-Dividend Date Dec 27, 2024
Volume 55,284
Open 22,300
Previous Close 22,800
Day's Range 22,150 - 23,000
52-Week Range 15,000 - 29,750
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 14, 2025

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2011
Employees 130
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

In 2023, L&C BIO Co.,LTD's revenue was 68.87 billion, an increase of 31.00% compared to the previous year's 52.57 billion. Earnings were 48.36 billion, an increase of 964.24%.

Financial Statements

News

There is no news available yet.